Atacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells.

scientific article

Atacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P698PubMed publication ID18951301

P2093author name stringBarbara Gatto
P433issue11
P407language of work or nameEnglishQ1860
P304page(s)1216-1227
P577publication date2008-11-01
P1433published inCurrent Opinion in Investigational DrugsQ15724634
P1476titleAtacicept, a homodimeric fusion protein for the potential treatment of diseases triggered by plasma cells
P478volume9

Reverse relations

cites work (P2860)
Q42038591B-cell tolerance in transplantation: is repertoire remodeling the answer?
Q34159016B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.
Q36443689Contemporary treatment of systemic lupus erythematosus: an update for clinicians.
Q37774242Control systems and decision making for antibody production.
Q39119839Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
Q33891669Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.
Q35857131TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice
Q47737016Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives.
Q38586922Targeting B-cell maturation antigen in multiple myeloma
Q96954523The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer
Q37728840The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease
Q52906655[Current therapeutic options in Sjögren's syndrome].

Search more.